|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| G01N 33/574 |
| (11) | Patento numeris | 2981821 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14778739.4 |
| Europos patento paraiškos padavimo data | 2014-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/032305 |
| Data | 2014-03-31 |
| (87) | Numeris | WO 2014/165422 |
| Data | 2014-10-09 |
| (30) | Numeris | Data | Šalis |
| 201361807581 P | 2013-04-02 | US |
| (72) |
DOLLED-FILHART, Marisa, US
EMANCIPATOR, Kenneth, US
LYNCH, Frank, US
PIERCE, Robert H., US
WU, Dianna, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | IMMUNOHISTOCHEMICAL ASSAY FOR DETECTING EXPRESSION OF PROGRAMMED DEATH LIGAND 1 (PD-L1) IN TUMOR TISSUE |
| IMMUNOHISTOCHEMICAL ASSAY FOR DETECTING EXPRESSION OF PROGRAMMED DEATH LIGAND 1 (PD-L1) IN TUMOR TISSUE |